Home  /  Resource Library  /  Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

Results of a phase II study investigating nivolumab in combination with chemotherapy for first line treatment of Hodgkin lymphoma.